Weihai Baihe Biology Technological Co., Ltd.

SHSE:603102 Stock Report

Market Cap: CN¥2.2b

Weihai Baihe Biology Technological Past Earnings Performance

Past criteria checks 2/6

Weihai Baihe Biology Technological has been growing earnings at an average annual rate of 10%, while the Personal Products industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 11% per year. Weihai Baihe Biology Technological's return on equity is 9.9%, and it has net margins of 18.6%.

Key information

10.0%

Earnings growth rate

2.5%

EPS growth rate

Personal Products Industry Growth7.8%
Revenue growth rate11.0%
Return on equity9.9%
Net Margin18.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Little Excitement Around Weihai Baihe Biology Technological Co., Ltd.'s (SHSE:603102) Earnings

Dec 23
Little Excitement Around Weihai Baihe Biology Technological Co., Ltd.'s (SHSE:603102) Earnings

Weihai Baihe Biology Technological (SHSE:603102) Could Be Struggling To Allocate Capital

Oct 01
Weihai Baihe Biology Technological (SHSE:603102) Could Be Struggling To Allocate Capital

Revenue & Expenses Breakdown

How Weihai Baihe Biology Technological makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603102 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2484515711531
30 Jun 2483515511831
31 Mar 2482815911832
31 Dec 2387116911931
30 Sep 2383916011629
30 Jun 2384516411027
31 Mar 2381115210324
31 Dec 227251389323
30 Sep 227111378520
30 Jun 226841518321
31 Mar 226631478523
31 Dec 216621488824
31 Dec 205781278521
31 Dec 19500748918
31 Dec 18507759018
31 Dec 17423647419
31 Dec 16365626620

Quality Earnings: 603102 has high quality earnings.

Growing Profit Margin: 603102's current net profit margins (18.6%) are lower than last year (19.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603102's earnings have grown by 10% per year over the past 5 years.

Accelerating Growth: 603102's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 603102 had negative earnings growth (-1.8%) over the past year, making it difficult to compare to the Personal Products industry average (-10.1%).


Return on Equity

High ROE: 603102's Return on Equity (9.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 03:01
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Weihai Baihe Biology Technological Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution